Detalhe da pesquisa
1.
Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C.
Liver Int
; 35(2): 429-37, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25308921
2.
Multiplex protein analysis to determine fibrosis stage and progression in patients with chronic hepatitis C.
Clin Gastroenterol Hepatol
; 12(12): 2113-20.e1-3, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24815325
3.
Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection.
Hum Genet
; 131(12): 1911-20, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22898894
4.
Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C.
J Hepatol
; 55(6): 1195-200, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21703198
5.
Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.
Hepatology
; 51(6): 1904-11, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20235331
6.
Liver-enriched transcription factors and their role in regulating UDP glucuronosyltransferase gene expression.
Curr Drug Metab
; 9(5): 439-52, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18537579
7.
Clinical trial of lamivudine in children with chronic hepatitis B.
N Engl J Med
; 346(22): 1706-13, 2002 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-12037150
8.
Polymorphic variations in the expression of the chemical detoxifying UDP glucuronosyltransferases.
Toxicol Appl Pharmacol
; 207(2 Suppl): 77-83, 2005 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15979674
9.
Regulation of UDP glucuronosyltransferase genes.
Curr Drug Metab
; 4(3): 249-57, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12769669
10.
Predictors of virologic response to Lamivudine treatment in children with chronic hepatitis B infection.
Pediatr Infect Dis J
; 23(5): 441-5, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15131468
11.
Extended treatment with lamivudine and adefovir dipivoxil in chronic hepatitis B patients with lamivudine resistance.
Hepatol Int
; 5(2): 654-63, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21484148
12.
Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B.
J Hepatol
; 48(5): 728-35, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18329126
13.
Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B.
J Hepatol
; 42(2): 173-9, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15664241
14.
A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus-related cirrhosis.
Liver Transpl
; 9(1): 49-56, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12514773
15.
Long-term safety of lamivudine treatment in patients with chronic hepatitis B.
Gastroenterology
; 125(6): 1714-22, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14724824
16.
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.
Hepatology
; 36(1): 186-94, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12085364
17.
Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy.
Gastroenterology
; 123(3): 719-27, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12198698